Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 18 04:00PM ET
1.03
Dollar change
+0.03
Percentage change
3.00
%
Index- P/E- EPS (ttm)-1.54 Insider Own3.89% Shs Outstand26.01M Perf Week7.53%
Market Cap26.79M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float24.99M Perf Month-4.63%
Income-26.95M PEG- EPS next Q-0.17 Inst Own14.19% Short Float4.41% Perf Quarter-13.45%
Sales0.35M P/S76.54 EPS this Y50.99% Inst Trans27.43% Short Ratio1.30 Perf Half Y-24.82%
Book/sh-0.27 P/B- EPS next Y- ROA-301.74% Short Interest1.10M Perf Year-75.12%
Cash/sh0.13 P/C7.83 EPS next 5Y- ROE-269476.55% 52W Range0.68 - 4.04 Perf YTD-7.21%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-74.50% Beta0.81
Dividend TTM- Quick Ratio0.38 Sales past 5Y148.40% Gross Margin-92.57% 52W Low51.47% ATR (14)0.13
Dividend Ex-Date- Current Ratio0.38 EPS Y/Y TTM40.41% Oper. Margin-8684.21% RSI (14)53.11 Volatility15.11% 13.54%
Employees30 Debt/Eq- Sales Y/Y TTM-95.07% Profit Margin-7700.63% Recom1.00 Target Price7.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q78.72% Payout- Rel Volume0.86 Prev Close1.00
Sales Surprise- EPS Surprise71.43% Sales Q/Q-100.00% EarningsFeb 13 BMO Avg Volume846.22K Price1.03
SMA208.47% SMA503.07% SMA200-25.13% Trades Volume730,049 Change3.00%
Date Action Analyst Rating Change Price Target Change
Jun-05-15Reiterated Canaccord Genuity Buy $4 → $6
Jan-12-15Reiterated ROTH Capital Buy $6 → $4
May-23-12Initiated Noble Financial Buy
Jan-23-07Initiated Next Generation Buy $5
Feb-14-25 03:20AM
02:18AM
Feb-13-25 07:30AM
Feb-10-25 04:00PM
Feb-07-25 08:00AM
07:01AM Loading…
07:01AM
Feb-06-25 07:30AM
Jan-28-25 07:30AM
Dec-20-24 07:41AM
Dec-19-24 07:30AM
Dec-16-24 07:30AM
Nov-25-24 07:30AM
Nov-15-24 05:24AM
02:15AM
Nov-14-24 07:30AM
09:57AM Loading…
Nov-08-24 09:57AM
Nov-04-24 07:30AM
Oct-31-24 07:30AM
Oct-24-24 07:30AM
Oct-23-24 07:30AM
Oct-07-24 04:15PM
Oct-02-24 06:54AM
03:00AM
Oct-01-24 07:30AM
Sep-30-24 09:01AM
Sep-26-24 07:30AM
Sep-09-24 07:30AM
Aug-28-24 07:30AM
Aug-23-24 04:52AM
Aug-22-24 07:30AM
08:00AM Loading…
Jun-21-24 08:00AM
04:32AM
Jun-20-24 07:30AM
Jun-13-24 06:52AM
Jun-12-24 07:30AM
May-20-24 12:00PM
May-16-24 03:05AM
01:46AM
May-15-24 07:30AM
May-09-24 07:30AM
May-02-24 07:30AM
Apr-30-24 07:30AM
Apr-14-24 03:00PM
Apr-09-24 08:59AM
Apr-08-24 12:02PM
07:30AM
Feb-28-24 07:30AM
Feb-16-24 10:00AM
12:55AM
Feb-15-24 07:30AM
Feb-09-24 07:30AM
Feb-05-24 07:30AM
Feb-01-24 04:00PM
Jan-30-24 08:00AM
Jan-11-24 01:38PM
Jan-08-24 10:33AM
Jan-03-24 08:00AM
Dec-23-23 05:00PM
Dec-20-23 07:30AM
Dec-18-23 04:15PM
Nov-15-23 03:01PM
03:29AM
Nov-14-23 07:30AM
Nov-09-23 07:30AM
Oct-24-23 04:50PM
Oct-23-23 07:30AM
Oct-19-23 08:45AM
07:30AM
Oct-18-23 07:30AM
Oct-16-23 07:30AM
Oct-13-23 04:15PM
Oct-03-23 08:35AM
Sep-29-23 01:34AM
Sep-28-23 07:30AM
Sep-22-23 04:00PM
Sep-07-23 04:00PM
07:30AM
Aug-10-23 07:30AM
Aug-08-23 07:30AM
Aug-07-23 07:30AM
Aug-04-23 07:30AM
Jul-11-23 07:30AM
May-30-23 07:30AM
May-17-23 01:39PM
01:33AM
May-16-23 08:45AM
07:30AM
May-15-23 09:05AM
May-11-23 05:25PM
04:15PM
May-09-23 05:45PM
07:30AM
May-08-23 04:04PM
May-01-23 04:00PM
Apr-27-23 07:30AM
Apr-25-23 07:30AM
Apr-19-23 07:30AM
Apr-18-23 07:30AM
Mar-02-23 07:30AM
Feb-28-23 07:30AM
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILLS STEPHEN TExecutive VP and CFO/COOAug 01 '24Sale1.664,9998,274235,456Aug 02 05:01 PM
DEVEER ROBERT K JRDirectorApr 11 '24Buy2.126,00012,70340,845Apr 11 04:45 PM
DEVEER ROBERT K JRDirectorMar 06 '24Sale2.0011,70023,43434,845Mar 07 05:02 PM